Impact of COVID-19 on in-hospital cardiac arrest outcomes: An updated meta-analysis

Karol Bielski1,2, Katarzyna Makowska3, Adam Makowski3

  • 1Research Unit, Polonia University, Czestochowa, Poland.

Cardiology Journal
|January 5, 2022
PubMed

Insights

The coronavirus disease 2019 (COVID-19) pandemic did not significantly alter in-hospital cardiac arrest (IHCA) outcomes. However, patients with severe acute respiratory syndrome coronavirus type 2 (SARS-CoV-2) infection experienced worse IHCA outcomes, including lower return of spontaneous circulation and higher mortality.

Area of Science:

  • Cardiology
  • Infectious Diseases
  • Critical Care Medicine

Background:

  • The COVID-19 pandemic has raised concerns regarding its impact on various medical outcomes.
  • In-hospital cardiac arrest (IHCA) is a critical event with significant morbidity and mortality.
  • Understanding the influence of the pandemic and SARS-CoV-2 infection on IHCA is crucial for clinical management.

Purpose of the Study:

  • To provide an updated meta-analysis on the effects of the COVID-19 pandemic on IHCA outcomes.
  • To specifically investigate the impact of SARS-CoV-2 infection on IHCA survival and success rates.

Main Methods:

  • This meta-analysis followed the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines.
  • Comparative analyses were performed for pre- and intra-COVID-19 periods.
  • Outcomes were compared between SARS-CoV-2 positive and negative patients.

Main Results:

  • No statistically significant differences were observed in shockable rhythms, return of spontaneous circulation (ROSC), 30-day mortality, or overall mortality between pre- and intra-COVID-19 periods.
  • Patients with SARS-CoV-2 infection showed a significantly lower incidence of shockable rhythms (9.6% vs. 19.8%) and ROSC (33.9% vs. 52.1%) compared to SARS-CoV-2 negative patients.
  • SARS-CoV-2 positive patients had a statistically significant higher 30-day mortality (77.2% vs. 59.7%) and a trend towards higher overall mortality (94.9% vs. 76.7%).

Conclusions:

  • The COVID-19 pandemic itself did not lead to statistically significant changes in IHCA outcomes when comparing pre- and intra-pandemic periods.
  • SARS-CoV-2 infection is associated with poorer IHCA outcomes, characterized by reduced ROSC and increased mortality.
  • These findings highlight the detrimental effect of SARS-CoV-2 on cardiac arrest resuscitation efforts and patient survival.
Abstract

Related Concept Videos

Cardiopulmonary Resuscitation IV: Pharmacological Management01:25

Cardiopulmonary Resuscitation IV: Pharmacological Management

Pharmacologic intervention is crucial in treating cardiac arrest patients during ACLS or Advanced Cardiovascular Life Support. The ACLS algorithms guide the administration of specific drugs based on the patient's cardiac arrest rhythm, which includes pulseless ventricular tachycardia (VT), ventricular fibrillation (VF), asystole, and pulseless electrical activity (PEA).EpinephrineIndication: Epinephrine is the first-line drug for all cardiac arrest rhythms.Mechanism of Action: Epinephrine...
105
Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
46
Cardiopulmonary Resuscitation III: AED Use01:23

Cardiopulmonary Resuscitation III: AED Use

Introduction to AEDAn Automated External Defibrillator (AED) is a portable medical device that analyzes the heart's rhythm and, if necessary, delivers an electrical shock to help the heart re-establish an effective rhythm during sudden cardiac arrest (SCA). SCA occurs when the heart suddenly and unexpectedly stops beating, leading to a loss of blood flow to the brain and other vital organs. In such emergencies, time is of the essence, and using an AED, combined with Cardiopulmonary...
110
Cardiopulmonary Resuscitation I: Adult01:21

Cardiopulmonary Resuscitation I: Adult

Cardiopulmonary resuscitation, or CPR, is a life-saving emergency procedure performed when a person's heart has stopped beating or they are no longer breathing. The foundation of CPR is Basic Life Support (BLS), which focuses on the early recognition of cardiac arrest, the immediate start of high-quality chest compressions, and the timely use of an automated external defibrillator (AED).Assessing Responsiveness and Checking the Carotid PulseWhen approaching an unresponsive person, first ensure...
156
Introduction Cardiac Emergencies01:30

Introduction Cardiac Emergencies

Cardiac emergencies are critical situations involving the heart that require immediate medical intervention to prevent severe complications or death. These emergencies often arise from underlying heart conditions that impair the heart's ability to function correctly.Types of Cardiac EmergenciesThe most common types of cardiac emergencies include Acute Coronary Syndrome (ACS), myocardial infarction (MI), cardiac arrest, and heart failure.Acute Coronary Syndrome (ACS)Acute Coronary Syndrome (ACS)...
60
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
40